Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 11, 2011 - Issue 1
Submit an article Journal homepage
304
Views
68
CrossRef citations to date
0
Altmetric
Review

miRNAs: roles and clinical applications in vascular disease

Md Saha Jamaluddin Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA; Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA
,
Sarah M Weakley Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA; Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA
,
Lidong Zhang Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA; Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA
,
Panagiotis Kougias Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA; Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA
,
Peter H Lin Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA; Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA
,
Qizhi Yao Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA; Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA
&
Changyi Chen Michael E DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, TX 77030, USA; Michael E DeBakey Veterans Affairs Medical Center, Houston, TX, USA. [email protected]; Michael E DeBakey Veterans Affairs Medical Center, Houston, TX, USA. [email protected]
 show all
Pages 79-89 | Published online: 09 Jan 2014

References

  • Stevens T, Garcia JG, Shasby DM, Bhattacharya J, Malik AB. Mechanisms regulating endothelial cell barrier function. Am. J. Physiol. Lung Cell. Mol. Physiol.279(3), L419–L422 (2000).
  • Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol.42(7), 1149–1160 (2003).
  • Endemann DH, Schiffrin EL. Endothelial dysfunction. J. Am. Soc. Nephrol.15(8), 1983–1992 (2004).
  • Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev.84(3), 767–801 (2004).
  • Zhang C. MicroRNAs: role in cardiovascular biology and disease. Clin. Sci. (Lond.)114(12), 699–706 (2008).
  • Zhang C. MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease. Cell Cycle8(21), 3469–3473 (2009).
  • Cheng Y, Liu X, Yang J et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res.105(2), 158–166 (2009).
  • Lee Y, Kim M, Han J et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J.23(20), 4051–4060 (2004).
  • Altuvia Y, Landgraf P, Lithwick G et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res.33(8), 2697–2706 (2005).
  • Lee Y, Ahn C, Han J et al. The nuclear RNase III Drosha initiates microRNA processing. Nature425(6956), 415–419 (2003).
  • Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the microprocessor complex. Nature432(7014), 231–235 (2004).
  • Gregory RI, Yan KP, Amuthan G et al. The Microprocessor complex mediates the genesis of microRNAs. Nature432(7014), 235–240 (2004).
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell116(2), 281–297 (2004).
  • Han J, Lee Y, Yeom KH et al. The Drosha–DGCR8 complex in primary microRNA processing. Genes Dev.18(24), 3016–3027 (2004).
  • Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev.17(24), 3011–3016 (2003).
  • Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA10(2), 185–191 (2004).
  • Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science303(5654), 95–98 (2004).
  • Hutvagner G, McLachlan J, Pasquinelli AE et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science293(5531), 834–838 (2001).
  • Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science293(5532), 1146–1150 (2001).
  • Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell115(7), 787–798 (2003).
  • Doench JG, Petersen CP, Sharp PA. siRNAs can function as miRNAs. Genes Dev.17(4), 438–442 (2003).
  • Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet.11(9), 597–610 (2010).
  • Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS ONE5(5), e10615 (2010).
  • Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control Drosha-mediated microRNA maturation. Nature454(7200), 56–61 (2008).
  • Xu C, Lu Y, Pan Z et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J. Cell Sci.120(Pt 17), 3045–3052 (2007).
  • Elia L, Contu R, Quintavalle M et al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation120(23), 2377–2385 (2009).
  • Parrizas M, Saltiel AR, LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3´-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem.272(1), 154–161 (1997).
  • Matsubara H, Takeuchi T, Nishikawa E et al. Apoptosis induction by antisense oligonucleotides against miR-17–5p and miR-20a in lung cancers overexpressing miR-17–92. Oncogene26(41), 6099–6105 (2007).
  • Cimmino A, Calin GA, Fabbri M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA102(39), 13944–13949 (2005).
  • Miranda KC, Huynh T, Tay Y et al. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell126(6), 1203–1217 (2006).
  • Zernecke A, Bidzhekov K, Noels H et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal.2(100), ra81 (2009).
  • Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med.16(5), 238–246 (2010).
  • Voghel G, Thorin-Trescases N, Farhat N et al. Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors. Mech. Ageing Dev.128(11–12), 662–671 (2007).
  • Zhao T, Li J, Chen AF. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab.299(1), E110–E116 (2010).
  • Potente M, Dimmeler S. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle7(14), 2117–2122 (2008).
  • Potente M, Ghaeni L, Baldessari D et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev.21(20), 2644–2658 (2007).
  • Menghini R, Casagrande V, Cardellini M et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation120(15), 1524–1532 (2009).
  • Poliseno L, Tuccoli A, Mariani L et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood108(9), 3068–3071 (2006).
  • Suarez Y, Fernandez-Hernando C, Yu J et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl Acad. Sci. USA105(37), 14082–14087 (2008).
  • Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res.101(1), 59–68 (2007).
  • Chen Y, Banda M, Speyer CL et al. Regulation of the expression and activity of the antiangiogenic homeobox gene GAX/MEOX2 by ZEB2 and microRNA-221. Mol. Cell. Biol.30(15), 3902–3913 (2010).
  • Anand S, Majeti BK, Acevedo LM et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med.16(8), 909–914 (2010).
  • Wang S, Aurora AB, Johnson BA et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell15(2), 261–271 (2008).
  • Fish JE, Santoro MM, Morton SU et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell15(2), 272–284 (2008).
  • Suarez Y, Sessa WC. MicroRNAs as novel regulators of angiogenesis. Circ. Res.104(4), 442–454 (2009).
  • Zhang C. MicroRNAs in vascular biology and vascular disease. J. Cardiovasc. Transl Res.3(3), 235–240 (2010).
  • van Solingen C, Seghers L, Bijkerk R et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J. Cell Mol. Med.13(8A), 1577–1585 (2009).
  • Bonauer A, Carmona G, Iwasaki M et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science324(5935), 1710–1713 (2009).
  • Minami Y, Satoh M, Maesawa C et al. Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur. J. Clin. Invest.39(5), 359–367 (2009).
  • Chen T, Huang Z, Wang L et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc. Res.83(1), 131–139 (2009).
  • Olkkonen VM, Levine TP. Oxysterol binding proteins: in more than one place at one time? Biochem. Cell Biol.82(1), 87–98 (2004).
  • Raychaudhuri S, Im YJ, Hurley JH, Prinz WA. Nonvesicular sterol movement from plasma membrane to ER requires oxysterol-binding protein-related proteins and phosphoinositides. J. Cell Biol.173(1), 107–119 (2006).
  • Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro.Proc. Natl Acad. Sci. USA107(30), 13450–13455 (2010).
  • Boettger T, Beetz N, Kostin S et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the miR143/145 gene cluster. J. Clin. Invest.119(9), 2634–2647 (2009).
  • Kawai-Kowase K, Owens GK. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol.292(1), C59–C69 (2007).
  • Parmacek MS. MicroRNA-modulated targeting of vascular smooth muscle cells. J. Clin. Invest.119(9), 2526–2528 (2009).
  • Cordes KR, Sheehy NT, White MP et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature460(7256), 705–710 (2009).
  • Elia L, Quintavalle M, Zhang J et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ.16(12), 1590–1598 (2009).
  • Xin M, Small EM, Sutherland LB et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev.23(18), 2166–2178 (2009).
  • Quintavalle M, Elia L, Condorelli G, Courtneidge SA. MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro.J. Cell Biol.189(1), 13–22 (2010).
  • Liu X, Cheng Y, Zhang S et al. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res.104(4), 476–487 (2009).
  • Dietschy JM, Turley SD. Control of cholesterol turnover in the mouse. J. Biol. Chem.277(6), 3801–3804 (2002).
  • Brown MS, Ye J, Goldstein JL. Medicine. HDL miR-ed down by SREBP introns. Science328(5985), 1495–1496 (2010).
  • Rayner KJ, Suarez Y, Davalos A et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science328(5985), 1570–1573 (2010).
  • Najafi-Shoushtari SH, Kristo F, Li Y et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science328(5985), 1566–1569 (2010).
  • Elmen J, Lindow M, Schutz S et al. LNA-mediated microRNA silencing in non-human primates. Nature452(7189), 896–899 (2008).
  • Esau C, Davis S, Murray SF et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab.3(2), 87–98 (2006).
  • Krutzfeldt J, Rajewsky N, Braich R et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature438(7068), 685–689 (2005).
  • Song H, Bu G. MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1. Biochem. Biophys. Res. Commun.388(2), 400–405 (2009).
  • Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol.284(1), R1–R12 (2003).
  • Davis ME, Grumbach IM, Fukai T, Cutchins A, Harrison DG. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kB binding. J. Biol. Chem.279(1), 163–168 (2004).
  • Weber M, Baker MB, Moore JP, Searles CD. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem. Biophys. Res. Commun.393(4), 643–648 (2010).
  • Chan LS, Yue PY, Mak NK, Wong RN. Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur. J. Pharm. Sci.38(4), 370–377 (2009).
  • Dentelli P, Rosso A, Orso F et al. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler. Thromb. Vasc. Biol.30(8), 1562–1568 (2010).
  • Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci.101(10), 2087–2092 (2010).
  • Gilad S, Meiri E, Yogev Y et al. Serum microRNAs are promising novel biomarkers. PLoS ONE3(9), e3148 (2008).
  • Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA105(30), 10513–10518 (2008).
  • Hunter MP, Ismail N, Zhang X et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE3(11), e3694 (2008).
  • D’Alessandra Y, Devanna P, Limana F et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J.31(22), 2765–2773 (2010).
  • Guo M, Mao X, Ji Q et al. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunol. Cell Biol.88(5), 555–564 (2010).
  • Ai J, Zhang R, Li Y et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem. Biophys. Res. Commun.391(1), 73–77 (2010).
  • Cheng Y, Tan N, Yang J et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin. Sci. (Lond.)119(2), 87–95 (2010).
  • Wang GK, Zhu JQ, Zhang JT et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J.31(6), 659–666 (2010).
  • Adachi T, Nakanishi M, Otsuka Y et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin. Chem.56(7), 1183–1185 (2010).
  • Ji X, Takahashi R, Hiura Y et al. Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem.55(11), 1944–1949 (2009).
  • Fichtlscherer S, De Rosa S, Fox H et al. Circulating microRNAs in patients with coronary artery disease. Circ. Res.107(5), 677–684 (2010).
  • Tan KS, Armugam A, Sepramaniam S et al. Expression profile of microRNAs in young stroke patients. PLoS ONE4(11), e7689 (2009).
  • Lee SD, Shroyer KR, Markham NE et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J. Clin. Invest.101(5), 927–934 (1998).
  • Caruso P, MacLean MR, Khanin R et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler. Thromb. Vasc. Biol.30(4), 716–723 (2010).
  • Chen Z, Nakajima T, Tanabe N et al. Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen a gene. Hum. Genet.128(4), 443–452 (2010).
  • Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann. NY Acad. Sci.936, 11–30 (2001).
  • Cheng Y, Zhang C. MicroRNA-21 in cardiovascular disease. J. Cardiovasc. Transl. Res.3(3), 251–255 (2010).
  • Ji R, Cheng Y, Yue J et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ. Res.100(11), 1579–1588 (2007).
  • Vendrov AE, Madamanchi NR, Hakim ZS, Rojas M, Runge MS. Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis. Circ. Res.98(10), 1254–1263 (2006).
  • Lin Y, Liu X, Cheng Y et al. Involvement of microRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J. Biol. Chem.284(12), 7903–7913 (2009).
  • Chan MC, Hilyard AC, Wu C et al. Molecular basis for antagonism between PDGF and the TGFb family of signalling pathways by control of miR-24 expression. EMBO J.29(3), 559–573 (2010).
  • Moser M, Patterson C. Bone morphogenetic proteins and vascular differentiation: BMPing up vasculogenesis. Thromb. Haemost.94(4), 713–718 (2005).
  • Fluiter K, Mook OR, Baas F. The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence. Methods Mol. Biol.487, 189–203 (2009).
  • van Rooij E, Marshall WS, Olson EN. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ. Res.103(9), 919–928 (2008).
  • Xiao J, Yang B, Lin H et al. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4.J. Cell. Physiol.212(2), 285–292 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.